A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining (Q84729355)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 October 2009

Language	Label	Description	Also known as
English	A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining	scientific article published on 15 October 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

based on heuristic

inferred from title

metastatic colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Rafal Wierzbicki

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Derek J Jonker

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Malcolm J Moore

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Scott R Berry

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Patrick J Loehrer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hagop Youssoufian

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Eric K Rowinsky

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

15 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

167-174

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19830388%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Monoclonal antibody therapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor expression and measurement in solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab for the treatment of colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of different scoring systems for immunohistochemical staining

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of an anti-epidermal growth factor receptor in treating cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19830388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84729355&oldid=2221646122"